Actively Recruiting
Augmented Reality BCI Longitudinal Study for Persons With Late Stage ALS
Led by Cognixion · Updated on 2025-02-05
10
Participants Needed
1
Research Sites
40 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this study is refine the usability of a BCI based communication platform. The study will take place in the greater Los Angeles area and will enroll up to 10 participants with late stage ALS. Each subject will receive a Cognixion Axon-R augmented reality brain computer interface and associated communication software. The study duration is 3 months for each participant. The key questions that will be addressed in this study are: 1. How quickly can participants learn and gain confidence with a pure BCI interface. 2. How effective are alternate input modalities including eye tracking for this use case. 3. Identify the extent to which generative AI based personalization impacts the communication quality. Key measures include: ITR - information transfer rate SUS - system usability scale
CONDITIONS
Official Title
Augmented Reality BCI Longitudinal Study for Persons With Late Stage ALS
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Must have a legally authorized representative who can consent and be present during the study
- Must have a designated person who can be trained to use the Cognixion system
- Fluent in understanding English
- 18 years or older
- Diagnosed with ALS and require an assistive communication device
- Able to open and maintain eye opening voluntarily for a certain duration
- Have a reliable way to communicate "Yes" and "No" outside of using the Cognixion device, such as vocalizations, head nods, eye blinks, or eyebrow raises
You will not qualify if you...
- Difficulty understanding English due to lack of fluency or language disorders such as aphasia
- Severe hearing loss or deafness
- Sensitivity to flashing lights
- History of epilepsy or seizures
- Vision problems limiting the visual field, including glaucoma, double vision, or involuntary eye movements
- History of vertigo or other balance disorders
- Scalp conditions prone to irritation, inflammation, injury, or infection
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Cognixion
Santa Barbara, California, United States, 93101-1665
Actively Recruiting
Research Team
C
Christopher Principal Investigator
CONTACT
C
Cole Study Coordinator
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DEVICE_FEASIBILITY
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here